carbamates has been researched along with Cancer of Prostate in 41 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Importantly, prostate cancer-derived SPOP mutants failed to interact with Cdc20 to promote its degradation." | 1.46 | Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation. ( Dai, X; Ding, Q; Gan, W; Li, M; Mitsiades, N; Wan, L; Wei, W; Wu, F; Zhang, J, 2017) |
| "Castration-resistant prostate cancer (CRPC) is still dependent on androgen receptor (AR) signaling." | 1.37 | Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291. ( Arai, S; Ishikura, N; Kawata, H; Nakagawa, T; Nakamura, R; Nishimoto, A; Sato, H; Shiraishi, T; Tachibana, K; Yoshino, H, 2011) |
| "Transfection of miR-17* into prostate cancer PC-3 cells significantly reduces levels of the three antioxidant proteins and activity of the luciferase reporter under the control of miR-17* binding sequences located in the 3'-untranslated regions of the three target genes." | 1.36 | miR-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes. ( Fang, F; Josson, S; St Clair, DK; St Clair, WH; Xu, Y; Zhang, J, 2010) |
| "Iejimalide B, has a dose and time dependent effect on cell number (as measured by crystal violet assay) in both cell lines." | 1.35 | Effects of Iejimalide B, a marine macrolide, on growth and apoptosis in prostate cancer cell lines. ( Helquist, P; Jeffrey, R; McHenry, P; Schweitzer, D; Tenniswood, M; Wang, WL, 2008) |
| "Carbamates 4 and 5 were 2." | 1.35 | Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells. ( Awate, B; Khanfar, MA; Liu, Y; Muralidharan, A; Nagle, DG; Sayed, KA; Shah, G; Shallal, HM; Youssef, DT; Zhou, YD, 2008) |
| "Prostate cancer bone metastases are characterized by their ability to induce osteoblastic lesions and local bone formation." | 1.32 | Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines. ( Abdulkadir, SA; McDonald, JM; Zayzafoon, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (39.02) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (21.95) | 29.6817 |
| 2010's | 14 (34.15) | 24.3611 |
| 2020's | 2 (4.88) | 2.80 |
| Authors | Studies |
|---|---|
| Panda, PK | 1 |
| Patra, S | 1 |
| Naik, PP | 1 |
| Praharaj, PP | 1 |
| Mukhopadhyay, S | 1 |
| Meher, BR | 1 |
| Gupta, PK | 1 |
| Verma, RS | 1 |
| Maiti, TK | 1 |
| Bhutia, SK | 1 |
| Huxley, C | 1 |
| Wibowo, M | 1 |
| Lum, KY | 1 |
| Gordon, S | 1 |
| D'Hyon, S | 1 |
| Guan, H | 1 |
| Wang, X | 1 |
| Chen, Y | 1 |
| Si, M | 1 |
| Wang, M | 1 |
| White, JM | 1 |
| Wahi, K | 1 |
| Wang, Q | 2 |
| Holst, J | 1 |
| Davis, RA | 1 |
| Noey, EL | 1 |
| Yang, Z | 1 |
| Li, Y | 1 |
| Yu, H | 1 |
| Richey, RN | 1 |
| Merritt, JM | 1 |
| Kjell, DP | 1 |
| Houk, KN | 1 |
| Bakthavatsalam, S | 1 |
| Sleeper, ML | 1 |
| Dharani, A | 1 |
| George, DJ | 1 |
| Zhang, T | 1 |
| Franz, KJ | 1 |
| Shi, J | 1 |
| Chen, J | 1 |
| Serradji, N | 1 |
| Xu, X | 1 |
| Zhou, H | 1 |
| Ma, Y | 1 |
| Sun, Z | 1 |
| Jiang, P | 1 |
| Du, Y | 1 |
| Yang, J | 1 |
| Dong, C | 1 |
| Schmidt, A | 2 |
| Meissner, RS | 1 |
| Gentile, MA | 2 |
| Chisamore, MJ | 2 |
| Opas, EE | 1 |
| Scafonas, A | 1 |
| Cusick, TE | 1 |
| Gambone, C | 2 |
| Pennypacker, B | 1 |
| Hodor, P | 1 |
| Perkins, JJ | 1 |
| Bai, C | 1 |
| Ferraro, D | 1 |
| Bettoun, DJ | 1 |
| Wilkinson, HA | 1 |
| Alves, SE | 2 |
| Flores, O | 2 |
| Ray, WJ | 1 |
| Djigoué, GB | 1 |
| Kenmogne, LC | 1 |
| Roy, J | 1 |
| Maltais, R | 1 |
| Poirier, D | 1 |
| Dillon, GM | 1 |
| Baran, M | 1 |
| Riley, S | 1 |
| Wilkinson, H | 1 |
| Wu, F | 1 |
| Dai, X | 1 |
| Gan, W | 1 |
| Wan, L | 1 |
| Li, M | 1 |
| Mitsiades, N | 1 |
| Wei, W | 1 |
| Ding, Q | 1 |
| Zhang, J | 2 |
| Gediya, LK | 1 |
| Khandelwal, A | 1 |
| Patel, J | 1 |
| Belosay, A | 1 |
| Sabnis, G | 1 |
| Mehta, J | 1 |
| Purushottamachar, P | 1 |
| Njar, VC | 2 |
| Moreira, VM | 1 |
| Vasaitis, TS | 1 |
| Guo, Z | 1 |
| Salvador, JA | 1 |
| Floryk, D | 1 |
| Thompson, TC | 1 |
| Wang, WL | 1 |
| McHenry, P | 1 |
| Jeffrey, R | 1 |
| Schweitzer, D | 1 |
| Helquist, P | 1 |
| Tenniswood, M | 1 |
| Garofalo, A | 1 |
| Goossens, L | 1 |
| Lemoine, A | 1 |
| Farce, A | 1 |
| Arlot, Y | 1 |
| Depreux, P | 1 |
| Byun, HS | 1 |
| Bittman, R | 1 |
| Samadder, P | 1 |
| Arthur, G | 1 |
| Xu, Y | 1 |
| Fang, F | 1 |
| Josson, S | 1 |
| St Clair, WH | 1 |
| St Clair, DK | 1 |
| Kawata, H | 1 |
| Arai, S | 1 |
| Nakagawa, T | 1 |
| Ishikura, N | 1 |
| Nishimoto, A | 1 |
| Yoshino, H | 1 |
| Shiraishi, T | 1 |
| Tachibana, K | 1 |
| Nakamura, R | 1 |
| Sato, H | 1 |
| Chang, JW | 1 |
| Nomura, DK | 1 |
| Cravatt, BF | 1 |
| Gagnepain, J | 1 |
| Moulin, E | 1 |
| Nevado, C | 1 |
| Waser, M | 1 |
| Maier, A | 1 |
| Kelter, G | 1 |
| Fiebig, HH | 1 |
| Fürstner, A | 1 |
| Andrieu, T | 1 |
| Bertolini, R | 1 |
| Nichols, SE | 1 |
| Setoud, R | 1 |
| Frey, FJ | 1 |
| Baker, ME | 1 |
| Frey, BM | 1 |
| Zayzafoon, M | 1 |
| Abdulkadir, SA | 1 |
| McDonald, JM | 1 |
| Libertini, SJ | 1 |
| Tepper, CG | 1 |
| Rodriguez, V | 1 |
| Asmuth, DM | 1 |
| Kung, HJ | 1 |
| Mudryj, M | 1 |
| Plano, D | 1 |
| Sanmartín, C | 1 |
| Moreno, E | 1 |
| Prior, C | 1 |
| Calvo, A | 1 |
| Palop, JA | 1 |
| Sayed, KA | 1 |
| Khanfar, MA | 1 |
| Shallal, HM | 1 |
| Muralidharan, A | 1 |
| Awate, B | 1 |
| Youssef, DT | 1 |
| Liu, Y | 1 |
| Zhou, YD | 1 |
| Nagle, DG | 1 |
| Shah, G | 1 |
| Ryan, CW | 1 |
| Shulman, KL | 1 |
| Richards, JM | 1 |
| Kugler, JW | 1 |
| Sosman, JA | 1 |
| Ansari, RH | 1 |
| Vokes, EE | 1 |
| Vogelzang, NJ | 1 |
| Kadohama, N | 1 |
| Kirdani, RY | 1 |
| Murphy, GP | 5 |
| Sandberg, AA | 1 |
| Mayer, EJ | 1 |
| Klein, D | 1 |
| Welvaart, K | 1 |
| Merrin, CE | 1 |
| Mittelman, A | 3 |
| Tritsch, GL | 1 |
| Shukla, SK | 2 |
| Erichsen, HG | 1 |
| Nygaard, E | 1 |
| de Leval, J | 1 |
| Petit, R | 1 |
| Bouffioux, C | 1 |
| Szendröi, Z | 2 |
| Könyves, I | 1 |
| Szendi, L | 1 |
| Eckhardt, S | 2 |
| Hartay, F | 1 |
| Zimel, H | 1 |
| Bocancea, D | 1 |
| Kocsár, L | 1 |
| Karika, Z | 1 |
| Füzi, M | 1 |
| Tarján, G | 1 |
| Reischel, G | 1 |
| Müntzing, J | 2 |
| Chu, TM | 1 |
| Nilsson, T | 1 |
| Polacek, J | 1 |
| Lindberg, B | 1 |
| Anderes, A | 1 |
| Arquint, A | 1 |
| Camponovo, F | 1 |
| Deppeler, O | 1 |
| Doerig, R | 1 |
| Heim, H | 1 |
| Humbert-Droz, P | 1 |
| Jung, HP | 1 |
| Magaro, L | 1 |
| Sasso, M | 1 |
| Vischer, C | 1 |
| Wanner, J | 1 |
| Wegmann, HJ | 1 |
| Ziegler, E | 1 |
| Jönsson, G | 1 |
2 trials available for carbamates and Cancer of Prostate
| Article | Year |
|---|---|
CI-980 in advanced melanoma and hormone refractory prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carbamates; Drug Resistance, Neoplasm; Female | 2000 |
Treatment of prostatic carcinoma with Stilbostat.
Topics: Aged; Carbamates; Clinical Trials as Topic; Diethylstilbestrol; Drug Evaluation; Humans; Injections, | 1974 |
39 other studies available for carbamates and Cancer of Prostate
| Article | Year |
|---|---|
Deacetylation of LAMP1 drives lipophagy-dependent generation of free fatty acids by Abrus agglutinin to promote senescence in prostate cancer.
Topics: Adenine; Apoptosis; Autophagy; Benzamides; Carbamates; Cell Line, Tumor; Cell Proliferation; Cellula | 2020 |
Synthesis of bilocularin A carbamate derivatives and their evaluation as leucine transport inhibitors in prostate cancer cells.
Topics: Australia; Carbamates; Humans; Leucine; Male; Molecular Structure; Prostatic Neoplasms; Sesquiterpen | 2020 |
Origins of Regioselectivity in the Fischer Indole Synthesis of a Selective Androgen Receptor Modulator.
Topics: Carbamates; Humans; Indoles; Male; Molecular Conformation; Molecular Dynamics Simulation; Prostatic | 2017 |
Leveraging γ-Glutamyl Transferase To Direct Cytotoxicity of Copper Dithiocarbamates against Prostate Cancer Cells.
Topics: Antineoplastic Agents; Carbamates; Cell Line, Tumor; Cell Survival; Copper; gamma-Glutamyltransferas | 2018 |
PMS1077 sensitizes TNF-α induced apoptosis in human prostate cancer cells by blocking NF-κB signaling pathway.
Topics: Apoptosis; Carbamates; Cell Line, Tumor; Cell Nucleus; Enzyme Activation; Gene Expression; Gene Expr | 2013 |
Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
Topics: Anabolic Agents; Androgen Receptor Antagonists; Androgens; Animals; Apoptosis; Azasteroids; Blotting | 2014 |
Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3.
Topics: 17-Hydroxysteroid Dehydrogenases; Androgens; Animals; Carbamates; Cell Line, Tumor; Drug Design; Enz | 2015 |
A novel selective androgen receptor modulator (SARM) MK-4541 exerts anti-androgenic activity in the prostate cancer xenograft R-3327G and anabolic activity on skeletal muscle mass & function in castrated mice.
Topics: Anabolic Agents; Androgen Antagonists; Animals; Antineoplastic Agents; Azasteroids; Carbamates; Carc | 2016 |
Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.
Topics: Antineoplastic Agents; Carbamates; Cdc20 Proteins; Cullin Proteins; Cyclopentanes; Diamines; Dose-Re | 2017 |
Design, synthesis, and evaluation of novel mutual prodrugs (hybrid drugs) of all-trans-retinoic acid and histone deacetylase inhibitors with enhanced anticancer activities in breast and prostate cancer cells in vitro.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carbamates; Cell Line, Tumor; Cell Proliferation; | 2008 |
Synthesis of novel C17 steroidal carbamates. Studies on CYP17 action, androgen receptor binding and function, and prostate cancer cell growth.
Topics: Carbamates; Cell Division; Cell Line, Tumor; Humans; Magnetic Resonance Spectroscopy; Male; Prostati | 2008 |
Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells.
Topics: Androgens; Apoptosis; Carbamates; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitor | 2008 |
Effects of Iejimalide B, a marine macrolide, on growth and apoptosis in prostate cancer cell lines.
Topics: Apoptosis; Carbamates; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Gene E | 2008 |
Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer.
Topics: Amides; Antineoplastic Agents; Carbamates; Cell Line, Tumor; Cell Proliferation; Drug Screening Assa | 2010 |
Synthesis and antitumor activity of ether glycerophospholipids bearing a carbamate moiety at the sn-2 position: selective sensitivity against prostate cancer cell lines.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Carbamates; Cell Line, Tumor; Drug | 2010 |
miR-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes.
Topics: Antioxidants; Carbamates; Cell Line, Tumor; Disulfiram; Gene Expression Regulation, Neoplastic; Glut | 2010 |
Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Anilides; Animals; Antineoplastic Agents; Carba | 2011 |
A potent and selective inhibitor of KIAA1363/AADACL1 that impairs prostate cancer pathogenesis.
Topics: Animals; Carbamates; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Discovery; Glyceryl Ethers | 2011 |
Molecular editing and assessment of the cytotoxic properties of iejimalide and progeny.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Products; Carbamates; Catalysis; Cell Line, Tu | 2011 |
A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.
Topics: Androgen Antagonists; Animals; Binding, Competitive; Carbamates; Cell Line, Tumor; Cell Proliferatio | 2011 |
Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines.
Topics: Basic Helix-Loop-Helix Transcription Factors; Blotting, Western; Bone Neoplasms; Calcium; Carbamates | 2004 |
Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence.
Topics: Androgens; Animals; Apoptosis; Calpain; Carbamates; Cell Line, Tumor; Dipeptides; Enzyme Activation; | 2007 |
Novel potent organoselenium compounds as cytotoxic agents in prostate cancer cells.
Topics: Carbamates; Cell Line, Tumor; Cell Proliferation; Humans; Imides; Male; Molecular Structure; Organos | 2007 |
Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells.
Topics: Animals; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Carbamates; Drug Screening Assay | 2008 |
Estramustine phosphate: metabolic aspects related to its action in prostatic cancer.
Topics: Adenocarcinoma; Animals; Carbamates; Culture Techniques; Estradiol; Estramustine; Humans; Hydrolysis | 1978 |
[Treatment of prostatic carcinoma with orally administered Estracyt].
Topics: Administration, Oral; Carbamates; Drug Evaluation; Estranes; Humans; Male; Nitrogen Mustard Compound | 1975 |
[Treatment with estramustine phosphate in advanced prostatic cancer].
Topics: Adenocarcinoma; Aged; Carbamates; Estranes; Humans; Male; Middle Aged; Nitrogen Mustard Compounds; P | 1972 |
Proceedings: Cancer of the prostate.
Topics: Amides; Antineoplastic Agents; Arginase; Bleomycin; Busulfan; Carbamates; Chromomycins; Cyclic P-Oxi | 1973 |
Stage D prostatic carcinoma. Survival rate in relapsed patients following new forms of palliation.
Topics: Adrenalectomy; Carbamates; Estranes; Humans; Hypophysectomy; Male; Neoplasm Metastasis; Nitrogen Mus | 1974 |
Estracyt (NSC 89199) as a substrate for phosphatases in human serum.
Topics: Acid Phosphatase; Alcohols; Alkaline Phosphatase; Antineoplastic Agents; Carbamates; Estranes; Human | 1974 |
[Prostatic cancer--treatment with extramustine phosphate(Estracyt). An easier application form].
Topics: Carbamates; Estradiol; Humans; Injections, Intra-Arterial; Male; Phosphates; Prostatic Neoplasms | 1974 |
[Preliminary results of 10 patients with advanced prostatic neoplasm treated with estracyt].
Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Carbamates; Estranes; Humans; Injections, Intravenous; | 1974 |
Estracyt in hormone-resistant prostatic carcinoma.
Topics: Adult; Aged; Carbamates; Carcinoma; Drug Evaluation; Drug Resistance; Estranes; Follow-Up Studies; H | 1974 |
Recent data on the mechanism of action of oestrogens in the treatment of prostatic tumour patients.
Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Carbamates; Castration; Estranes; Humans; Iodine Radioi | 1974 |
Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate.
Topics: Acid Phosphatase; Administration, Oral; Antineoplastic Agents; Carbamates; Carcinoembryonic Antigen; | 1974 |
Zinc and beta-glucuronidase in the human prostate.
Topics: Adenocarcinoma; Biopsy, Needle; Carbamates; Estradiol; Ethinyl Estradiol; Glucuronidase; Humans; Mal | 1974 |
Treatment of rapidly progressing prostatic carcinoma with estracyt.
Topics: Aged; Antineoplastic Agents; Carbamates; Estranes; Estrogens; Humans; Male; Middle Aged; Neoplasm Me | 1972 |
[Cytostatic treatment of prostatic carcinoma. Evaluation study of estramustinphosphate].
Topics: Aged; Carbamates; Estrogens; Evaluation Studies as Topic; Humans; Male; Middle Aged; Nitrogen Mustar | 1971 |
"Estracyt".
Topics: Carbamates; Estradiol; Humans; Male; Neoplasm Metastasis; Nitrogen Mustard Compounds; Prostatic Neop | 1971 |